In a world where medical costs spiral ever higher, insurance companies have begun to scrutinize the effectiveness and necessity of certain treatments like never before. Some procedures that once sailed through approvals are now being flagged as outdated, overused, or simply not worth the risk for the price. Patients, doctors, and hospitals are suddenly facing tougher questions about whether these interventions actually deliver the results they promise.
This new wave of accountability is forcing the medical community to reconsider practices that have long been taken for granted.
